B2UYI1 AF NFT

Argininosuccinate lyase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeie2iigs3pmpissd47mpzvc6elesj2mpjs555alsyyvlspt5f4pzxi/metadata.json
IPFS of structure file: 
bafybeichlfuojaajgdvr4sjx7yv3tkvhf2brjxw5xjy7vdr247mgzufswe/AF-B2UYI1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xB05a6C07895e32B47A59E248baa07d66d77b0e17
First NFT owner address (bech32): 
genesis1kpdxcpuftcetg7jeufyt4gravmthkrshkmq5vl
Current NFT ID #23042 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
23042
Accession (UniProt):
B2UYI1
Name::
Argininosuccinate lyase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2UYI1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2UYI1|ARLY_CLOBA Argininosuccinate lyase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=argH PE=3 SV=1 MKLWGGRFKKGTDELVNDFNSSINIDSRMYKEDIEGSLAHASMLGEQNIISKEDSLKITSGLLEILKRMDNDVINIDLTSEDIHSFVESTLTYYIGEYGKMLHTARSRNDQVTLDLKLYLKKALVKLRKDILYLEEVLLEKSKEHISTIMPGYTHMQKAQPITLSHHLLAYAEMFKRDIGRINDAYKRTDEMPLGSGALATSTYPIDRYMVAKDLGFSKITLNSLDSVSDRDYVIETLSALSLIMMHLSRFSEEIILWCTGEFNFVELDDSYSTGSSIMPQKKNPDVAELIRGKTGRVYGDLITLLTVMKGIPLAYNKDMQEDKEALFDALDTVTLSLKTFAGMIKTMKINKDNMKKSAALGFTNATDLADYLVKKGSYFRDAHGIVGQIVLQCIKDNKMIEDLTLAELKEYSPTFEEDVYDAINLYTCVEERKVIGGPSRESVKFQIKELQEFIHQFKGDEIYD